The Scottish speciality pharmaceutical company ProStrakan has received a £292 M (US$475 M) cash takeover bid from Japan’s Kyowa Hakko Kirin. ProStrakan put itself up for sale in November 2010 following a number of manufacturing and regulatory setbacks in the US that depressed its share price and led to an unsolicited tender offer from Norgine. The acquisition will enable Kyowa Hakko Kirin to establish a stronger foothold in foreign markets.